Corrigendum: miR-21 in Human Cardiomyopathies.
biomarkers
cardiomyopathies
fibrosis
miR-21
targeted therapy
Journal
Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388
Informations de publication
Date de publication:
2022
2022
Historique:
received:
05
04
2022
accepted:
06
04
2022
entrez:
13
5
2022
pubmed:
14
5
2022
medline:
14
5
2022
Statut:
epublish
Résumé
[This corrects the article DOI: 10.3389/fcvm.2021.767064.].
Identifiants
pubmed: 35548429
doi: 10.3389/fcvm.2022.913429
pmc: PMC9083824
doi:
Types de publication
Published Erratum
Langues
eng
Pagination
913429Commentaires et corrections
Type : ErratumFor
Informations de copyright
Copyright © 2022 Surina, Fontanella, Scisciola, Marfella, Paolisso and Barbieri.